Sodium-glucose cotransporter-2 (SGLT2) inhibitors, also known as gliflozins, lower blood sugar by prompting the kidneys to ...

Researchers have found that people who take a type of type 2 diabetes drugs SGLT2 inhibitors have a significantly lower risk ...

According to a study a class of diabetes medications may be linked to a decreased risk of dementia and Parkinson disease ...

A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson’s disease, according to a study ...

Diabetes medications, specifically sodium-glucose cotransporter-2 (SGLT2) inhibitors, may be linked to a decreased risk of ...

Hae Kyung Kim, M.D., from the Yonsei University College of Medicine in Seoul, South Korea, and colleagues examined the ...

Sodium-glucose cotransporter-2 (SGLT2) inhibitors, a class of diabetes drugs also known as gliflozins, could lower the risk ...

The collective research from FLOW and other trials has resulted in recommendations of a four-pillar approach for the ...